[ALNY] YoY Quarter Result on 30-Sep-2009 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
04-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 59.44%
YoY- -222.18%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Revenue 16,759 20,791 27,668 24,249 25,734 16,315 8,211 12.61%
PBT -19,502 -13,237 -9,332 -9,760 -3,651 -47,607 -7,400 17.51%
Tax -2,543 -930 298 -552 -793 5,185 -1,204 13.25%
NP -19,502 -13,237 -9,630 -9,208 -2,858 -52,792 -7,400 17.51%
Tax Rate - - - - - - - -
Total Cost 36,261 34,028 37,298 33,457 28,592 69,107 15,611 15.06%
Ratio Analysis
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
NP Margin -116.37 -63.67 -34.81 -37.97 -11.11 -323.58 -90.12 4.34%
Per Share
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
EPS -0.38 -0.31 -0.23 -0.22 -0.07 -1.35 -0.23 8.72%
EPS Diluted -0.38 -0.31 -0.23 -0.22 -0.07 -1.35 -0.23 8.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.